Grant: CIHR Fellowship
McMaster University
$90,000.00
Characterization of the roles and molecular mechanism of adrenomedullin1 and its receptor in hematopoiesis
EF 2008-09
Résumé
Embryonic stem cells (ESC), as the name indicates, are derived from embryos. They have unlimited self-renewal capacity and they can transform to any type of cell in an animal. Therefore, they have been considered as an important clinical resource for the treatment of many diseases e.g., blood cancer. Human ESC (hESC) have been established as a suitable source of blood formation in a laboratory system with the treatment of specified bio-molecules but it is not efficient enough. Therefore, discovery of novel bio-molecules, which regulate the blood-cell formation from hESC, and understanding of the relevant mechanism will provide novel means for the efficient manipulation of hESC that ultimately will lead to the effective treatment for blood-related diseases. Our study revealed that adrenomedullin 1 (AM1), a multifunctional peptide hormone, and its receptor system, which is a combination of calcitonin receptor-like receptor (CLR) and receptor activity modifying protein (RAMP) 2, are linked with the blood formation in zebrafish, because forced inhibition of AM1 receptor activity in zebrafish embryo developed blood-less animal. We further revealed that the blood-forming function of AM1-signaling pathway is also conserved in human since the blood-forming tissues express high level of CLR, and AM1 treatment augmented hESC-derived blood-cell formation in laboratory condition via Notch-signaling pathway, an established signaling pathway related to blood-cell formation from hESC. Based on our current data we hypothesized that AM1 synergistically works with other known blood-cell forming factors. However, further study is required to reveal the underlying molecular circuitry of the phenomenon. Our discovery that AM1 and its receptor system potentiate blood-cell formation from hESC is very influential and novel information for the treatment of blood-related diseases.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
173503
Name
Nag Kakon
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Characterization of the roles and molecular mechanism of adrenomedullin1 and its receptor in hematopoiesis
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Hematopoiesis From Human Embryonic Stem Cell
Abstract
Embryonic stem cells (ESC), as the name indicates, are derived from embryos. They have unlimited self-renewal capacity and they can transform to any type of cell in an animal. Therefore, they have been considered as an important clinical resource for the treatment of many diseases e.g., blood cancer. Human ESC (hESC) have been established as a suitable source of blood formation in a laboratory system with the treatment of specified bio-molecules but it is not efficient enough. Therefore, discovery of novel bio-molecules, which regulate the blood-cell formation from hESC, and understanding of the relevant mechanism will provide novel means for the efficient manipulation of hESC that ultimately will lead to the effective treatment for blood-related diseases. Our study revealed that adrenomedullin 1 (AM1), a multifunctional peptide hormone, and its receptor system, which is a combination of calcitonin receptor-like receptor (CLR) and receptor activity modifying protein (RAMP) 2, are linked with the blood formation in zebrafish, because forced inhibition of AM1 receptor activity in zebrafish embryo developed blood-less animal. We further revealed that the blood-forming function of AM1-signaling pathway is also conserved in human since the blood-forming tissues express high level of CLR, and AM1 treatment augmented hESC-derived blood-cell formation in laboratory condition via Notch-signaling pathway, an established signaling pathway related to blood-cell formation from hESC. Based on our current data we hypothesized that AM1 synergistically works with other known blood-cell forming factors. However, further study is required to reveal the underlying molecular circuitry of the phenomenon. Our discovery that AM1 and its receptor system potentiate blood-cell formation from hESC is very influential and novel information for the treatment of blood-related diseases.
Competitiondate
200810
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Nag, Kakon
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $90,000~ $0~